lab testers: Pass on DGX. Read something negative about their business practices. LH--Began buying small in Nov. Averaging down as stock falls. Most recent add yesterday. In total, a very small token amount.
With Affordable/Obama care, more people will get tests. Otoh, many patients will be charged (out of pocket), so patients may not so easily opt for many tests. Plus Medicad/Medicare payments may go lower. So difficult to be certain to what extent LH/others will benefit, if at all. As stated in previous LH discussion here, some indication that big hospital chains are preferring to do their testing in-house, bypassing companies like LH. Or if testing isn't profitable for them, maybe the healthcare firms are outsourcing, as stated in previous post.
Note all the new tests/business LH seems to be contracting for:
finance.yahoo.com
For me, I hope reversion-to-mean for the stock. Risk being, government/ business model
has shifted to permanently impair prospects for LH other testing co's. |
